 |
 |
|
|
RESÚMENES ABRIL 2005 |
Basic Neuroscience & Pharmacology
(Requiere estar conectado a internet. Haga un click en la
información del journal)
Effects of Tryptophan Depletion on Serum Levels of Brain-Derived Neurotrophic Factor in Unmedicated Patients With Remitted Depression and Healthy Subjects
Alexander Neumeister, Peixiong Yuan, Theresa A. Young, Omer Bonne,
David A. Luckenbaugh, Dennis S. Charney, Husseini Manji
Am J Psychiatry 162:805-807, April 2005
G protein bg directly regulates SNARE protein fusion
machinery for secretory granule exocytosis
Nature Neuroscience 8, 421 - 425 (2005)
Control of
synaptic strength and timing by the release-site Ca2+ signal
Nature Neuroscience 8, 426 - 434 (2005)
Nature Neuroscience 8, 468 - 475 (2005)
Nature Neuroscience 8, 519 - 526 (2005)
Simon
Rumpel, Joseph LeDoux, Anthony Zador, Roberto Malinow
SCIENCE VOL 308 1 APRIL 2005: 83-88
Yashmin J.G.
Karten, Ana Olariu and Heather A. Cameron
Trends
in Neurosciences. Volume 28, Issue 4, April 2005, Pages 171-172
DENDRITIC SPINES AND LONG-TERM
PLASTICITY
Nature Reviews Neuroscience 6, 277-284 (2005)
NORMAL
AND PATHOLOGICAL OSCILLATORY COMMUNICATION IN THE BRAIN
Nature Reviews Neuroscience 6, 285-296 (2005)
CORTICAL
INHIBITORY NEURONS AND SCHIZOPHRENIA
Nature Reviews Neuroscience 6, 312-324 (2005)
Histaminergic
modulation of excitatory synaptic transmission in the rat basolateral amygdala
X. Jiang, A. Chen
and H. Li
Neuroscience. Volume 131, Issue 3, 2005, Pages 691-703
Male patients with
paranoid schizophrenia have greater ACTH and cortisol secretion in response to
metoclopramide-induced AVP release
Patricia Walsh,
Leona Spelman, Neda Sharifi and Jogin H. Thakore
Psychoneuroendocrinology. Volume 30, Issue 5, June 2005, Pages
431-437
Anthony W.
Bachmann, Teresa L. Sedgley, Richard V. Jackson, John N. Gibson, Ross McD.
Young and David J. Torpy
Psychoneuroendocrinology. Volume 30, Issue 3, April 2005, Pages
297-306
K. Pham, B.S.
McEwen, J.E. Ledoux and K. Nader
Neuroscience. Volume 130, Issue 1, 2005, Pages 17-24
B.J. Casey, Nim
Tottenham, Conor Liston and Sarah Durston
Trends
in Cognitive Sciences. Volume 9, Issue 3, March 2005, Pages 104-110
Cytokine
production and modulation: Comparison of patients with chronic fatigue syndrome
and normal controls
Akemi Tomoda,
Takako Joudoi, El-Mezayen Rabab, Tomoaki Matsumoto, T.H. Park and Teruhisa
Miike
Psychiatry Research. Volume 134, Issue 1, 30 March 2005, Pages
101-104
Controlled clinical comparison of paroxetine and fluvoxamine considering
the serotonin transporter promoter polymorphism.
Kato, Masaki; Ikenaga, Yuka; Wakeno,
Masataka; Okugawa, Gaku; Nobuhara, Kenji; Fukuda, Tsuyoshi; Fukuda, Kazuhiro;
Azuma, Junichi; Kinoshita, Toshihiko
International
Clinical Psychopharmacology. 20(3):151-156, May 2005
Reduced
hippocampal volume in unmedicated, remitted patients with major depression
versus control subjects
Alexander
Neumeister, Suzanne Wood, Omer Bonne, Allison C. Nugent, David A. Luckenbaugh,
Theresa Young, Earle E. Bain, Dennis S. Charney and Wayne C. Drevets
Biological Psychiatry. Volume 57, Issue 8, 15 April 2005, Pages
935-937
Chronic
administration of the SSRI fluvoxamine markedly and selectively reduces the
sensitivity of cortical serotonergic neurons to footshock stress
Laura Dazzi,
Emanuele Seu, Giulia Cherchi and Giovanni Biggio
European Neuropsychopharmacology. Volume 15, Issue 3,
May 2005, Pages 283-290
Rael D. Strous,
Pavel Golubchik, Rachel Maayan, Tamar Mozes, Dafna Tuati-Werner, Abraham
Weizman and Baruch Spivak
European Neuropsychopharmacology. Volume 15, Issue 3,
May 2005, Pages 305-309
Effect of chronic
olanzapine treatment on nerve growth factor and brain-derived neurotrophic
factor in the rat brain
Francesco
Angelucci, Luigi Aloe, Angela Iannitelli, Susanne H.M. Gruber and Aleksander A.
Mathé
European Neuropsychopharmacology. Volume 15, Issue 3,
May 2005, Pages 311-317
Gal Shoval and
Abraham Weizman
European Neuropsychopharmacology. Volume 15, Issue 3,
May 2005, Pages 319-329
Neurobiology of
emotion and high risk for schizophrenia: role of the amygdala and the
X-chromosome
Sophie van Rijn,
André Aleman, Hanna Swaab and René S. Kahn
Neuroscience & Biobehavioral Reviews. Volume 29,
Issue 3, May 2005, Pages 385-397
The SNAP-25 gene
may be associated with clinical response and weight gain in antipsychotic
treatment of schizophrenia
Daniel J. Müller,
Tim A. Klempan, Vincenzo De Luca, Tricia Sicard, Jan Volavka, Pal Czobor, Brian
B. Sheitman, Jean-Pierre Lindenmayer, Leslie Citrome, Joseph P. McEvoy, Jeffrey
A. Lieberman, William G. Honer and James L. Kennedy
Neuroscience
Letters. Volume 379, Issue 2, 6 May 2005, Pages 81-89
AMPA receptor
stimulation mediates the antidepressant-like effect of a group II metabotropic
glutamate receptor antagonist
Jun-ichi Karasawa,
Toshiharu Shimazaki, Naoya Kawashima and Shigeyuki Chaki
Brain Research. Volume 1042, Issue 1, 25 April 2005, Pages 92-98
Quetiapine (Seroquel) shows a pattern of behavioral effects similar to
the atypical antipsychotics clozapine and olanzapine: studies with tremulous
jaw movements in rats
Psychopharmacology 2005; Volume 179, Number
2: 383 - 392
Implication of 5-HT2 receptor subtypes in the mechanism of
action of antidepressants in the four plates test
Psychopharmacology 2005; Volume 179, Number
2: 418 - 429
Stable expression of constitutively activated mutant h5HT6
and h5HT7 serotonin receptors: inverse agonist activity of
antipsychotic drugs
Psychopharmacology 2005; Volume 179, Number
2: 461 - 469
Quantitative analysis of the effects of some “atypical” and
“conventional” antipsychotics on progressive ratio schedule performance
Z. Zhang, J. F. Rickard,
K. Asgari, S. Body, C. M. Bradshaw and E. Szabadi
Psychopharmacology 2005; Volume 179, Number
2: 489 - 497
The
Antiepileptic Drug Levetiracetam Decreases the Inositol
1,4,5-Trisphosphate-Dependent [Ca2+]i Increase Induced by
ATP and Bradykinin in PC12 Cells
Mauro Cataldi, Vincenzo Lariccia, Agnese Secondo, Gianfranco di Renzo,
and Lucio Annunziato
Time-Dependent Changes in Receptor/G-Protein Coupling in Rat Brain following Chronic Monoamine Transporter Blockade
Kerry A. O'Connor, Linda J. Porrino, Huw M. L. Davies, and Steven R.
Childers
Clozapine
Potentiation of N-Methyl-D-aspartate
Receptor Currents in the Nucleus Accumbens: Role of NR2B and Protein Kinase
A/Src Kinases
Marion Wittmann, Michael J. Marino, Darrell A. Henze, Guy R. Seabrook,
and P. Jeffrey Conn
Anxiolytic- and Antidepressant-Like Profile of ATC0065 and ATC0175: Nonpeptidic and Orally Active Melanin-Concentrating Hormone Receptor 1 Antagonists
Shigeyuki Chaki, Takeo Funakoshi, Shiho Hirota-Okuno, Mariko Nishiguchi,
Toshiharu Shimazaki, Michihiko Iijima, Andrew J. Grottick, Kosuke Kanuma,
Katsunori Omodera, Yoshinori Sekiguchi, Shigeru Okuyama, Thuy-Anh Tran, Graeme
Semple, and William Thomsen
Methylphenidate
(Ritalin) induces Homer 1a and zif 268 expression in specific corticostriatal
circuits
M. Yano and H.
Steiner
Neuroscience. Volume 132, Issue 3, 2005, Pages 855-865
The therapeutic
effects of dopamine replacement therapy and its psychiatric side effects are
mediated by pineal function
Gregory L. Willis
Behavioural
Brain Research. Volume 160, Issue 1, 7 May 2005, Pages 148-160
Chronic
administration of quetiapine alleviates the anxiety-like behavioural changes
induced by a neurotoxic regimen of dl-amphetamine in rats
Jue He, Haiyun Xu,
Yi Yang, Xia Zhang and Xin-Min Li
Behavioural
Brain Research. Volume 160, Issue 1, 7 May 2005, Pages 178-187
5-HT2A
and muscarinic receptors in schizophrenia: a postmortem study
Izuru Matsumoto,
Yuki Inoue, Takeshi Iwazaki, Geoff Pavey and Brian Dean
Neuroscience Letters. Volume 379, Issue 3, 13 May
2005, Pages 164-168
Genomic
characterization of Alzheimer's disease and genotype-related phenotypic
analysis of biological markers in dementia
Ramón
Cacabelos
Pharmacogenomics. 2004, vol. 5, no. 8, pp. 1049 - 1105
Plasma
level-dependent effects of methylphenidate on task-related functional magnetic
resonance imaging signal changes.
Muller U, Suckling J,
Zelaya F, Honey G, Faessel H, Williams SC, Routledge C, Brown J, Robbins TW,
Bullmore ET
Psychopharmacology (Berl). 2005 Apr 14; [Epub ahead of
print]
Activation
of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted
subjects but not in controls: relevance to addiction.
Volkow ND, Wang GJ, Ma Y,
Fowler JS, Wong C, Ding YS, Hitzemann R, Swanson JM, Kalivas P
J Neurosci. 2005 Apr 13;25(15):3932-9
Eduard Maron,
Aavo Lang, Gunnar Tasa, Liivi Liivlaid, Innar Tőru,
Anne Must, Veiko Vasar and Jakov Shlik
The International Journal of Neuropsychopharmacology
(2005), 8:2:261-266
Association
between three functional polymorphisms of the dopamine D2 receptor gene and
polydipsia in schizophrenia
Chima Matsumoto,
Takahiro Shinkai, Vincenzo De Luca, Rudi Hwang,
Hiroko Hori, Matthew Lanktree, Osamu Ohmori, James
L. Kennedy and Jun Nakamura
The International Journal of Neuropsychopharmacology
(2005), 8:2:245-253
Polymorphisms in
wolframin (WFS1) gene are possibly related to increased risk for mood disorders
Kati Koido,
Sulev Kőks, Tiit Nikopensius, Eduard Maron, Signe Altmäe,
Evelin Heinaste, Kristel Vabrit, Veronika Tammekivi,
Pille Hallast, Ants Kurg, Jakov Shlik, Veiko Vasar,
Andres Metspalu and Eero Vasar
The International Journal of Neuropsychopharmacology
(2005), 8:2:235-244
Topography of Methylphenidate (Ritalin)-Induced Gene
Regulation in the Striatum: Differential Effects on c-Fos, Substance P and
Opioid Peptides
Motoyo Yano and Heinz Steiner
Neuropsychopharmacology (2005) 30, 901-915
Altered Expression of 14-3-3 Genes in the Prefrontal Cortex
of Subjects with Schizophrenia
Frank A Middleton, Lansha Peng,
David A Lewis, Pat Levitt and Karoly Mirnics
Neuropsychopharmacology (2005) 30, 974-983
Reduced Density of Platelet-Binding Sites for [3H]Paroxetine
in Remitted Bulimic Women
Howard Steiger, Jodie Richardson,
Mimi Israel, N M K Ng Ying Kin, Kenneth Bruce, Sandra Mansour and Anne Marie
Parent
Neuropsychopharmacology (2005) 30, 1028-1032
D. A. F. Robertson, J. E. Beattie, I. C. Reid and
D. J. K. Balfour
European Journal of Neuroscience. Volume 21 Issue
6 Page 1511 - March 2005
Mona
Boules; Paul Fredrickson; Elliott Richelson
Expert Opinion on Investigational Drugs. 2005, vol. 14, no. 4, pp.
359 - 369
Andreas S. Beutler,
SiDe Li, Rebekka Nicol and Martin J. Walsh
Life
Sciences. Volume 76, Issue 26, 13 May 2005, Pages 3107-3115
Monoaminergic
dysregulation in glutathione-deficient mice: Possible relevance to
schizophrenia?
J.P.R. Jacobsen,
R.M. Rodriguiz, A. Mřrk and W.C. Wetsel
Neuroscience. Volume 132, Issue 4, 2005, Pages
1055-1072
Fumihiko Yasuno,
Tetsuya Suhara, Yoshiro Okubo, Tetsuya Ichimiya, Akihiro Takano, Yasuhiko Sudo
and Makoto Inoue
Psychiatry Research: Neuroimaging. Volume 138, Issue
3, 30 April 2005, Pages 197-207
Abnormal
development of the anterior cingulate in childhood-onset schizophrenia: a
preliminary quantitative MRI study
Renée K. Marquardt,
Jennifer G. Levitt, Rebecca E. Blanton, Rochelle Caplan, Robert Asarnow, Prabha
Siddarth, David Fadale, James T. McCracken and Arthur W. Toga
Psychiatry Research: Neuroimaging. Volume 138, Issue
3, 30 April 2005, Pages 221-233
Marco A. Riva,
Raffaella Molteni, Francesco Bedogni, Giorgio Racagni and Fabio Fumagalli
Trends
in Pharmacological Sciences. Volume 26, Issue 5, May 2005, Pages 228-231
Antipsychotic
drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the
rat
Matthew L.
MacDonald, Molly E. Eaton, Joshua T. Dudman and Christine Konradi
Biological Psychiatry. Volume 57, Issue 9, 1 May 2005, Pages
1041-1051
Cognitive
impairment in aged rhesus monkeys associated with monoamine receptors in the
prefrontal cortex
Tara L. Moore,
Stephen P. Schettler, Ronald J. Killiany, James G. Herndon, Jennifer I. Luebke,
Mark B. Moss and Douglas L. Rosene
Behavioural
Brain Research. Volume 160, Issue 2, 28 May 2005, Pages 208-221
Isabel Pérez-Otańo
and Michael D. Ehlers
Trends
in Neurosciences. Volume 28, Issue 5, May 2005, Pages 229-238
Clozapine,
ziprasidone and aripiprazole but not haloperidol protect against kainic
acid-induced lesion of the striatum in mice, in vivo: Role of 5-HT1A
receptor activation
Cristina Cosi,
Aurelie Waget, Karin Rollet, Valentina Tesori and Adrian Newman-Tancredi
Brain Research. Volume 1043, Issues 1-2, 10 May 2005, Pages 32-41
Effects of
depression, cigarette smoking, and age on monoamine oxidase B in amygdaloid
nuclei
Beata Karolewicz,
Violetta Klimek, He Zhu, Katalin Szebeni, Emily Nail, Craig A. Stockmeier,
Laurel Johnson and Gregory A. Ordway
Brain Research. Volume 1043, Issues 1-2, 10 May 2005, Pages 57-64
Role
of brain-derived neurotrophic factor in eating disorders: Recent findings and
its
pathophysiological implications
Effects of
antidepressant treatment and of gender on serum leptin levels in patients with
major depression
Ertugrul Esel,
Saliha Ozsoy, Ahmet Tutus, Seher Sofuoglu, Sukru Kartalci, Fahri Bayram, Zaliha
Kokbudak and Mustafa Kula
Nicotine
and clozapine actions on pre-pulse inhibition deficits caused by N-methyl-d-aspartate (NMDA) glutamatergic receptor blockade
Edward D. Levin,
Ann Petro and D. Patrick Caldwell
Pharmacopsychiatry. 2005 May;38(3):113-7
A screening
study of antidepressant treatment rates and mood symptoms in pregnancy
S. M. Marcus,
H. A. Flynn, F. Blow and K. Barry
Archives
of Women's Mental Health 2005; Volume 8, Number 1: 25 - 27
Exposure
measures applied to the bioequivalence of two sustained release formulations of
bupropion
Midha KK, Rawson MJ, McKay G, Hubbard JW
Int J Clin Pharmacol Ther. 2005 May;43(5):244-54
Lachlan A.
McWilliams, Brian J. Cox and Gordon J.G. Asmundson
Journal
of Anxiety Disorders. Volume 19, Issue 6, 2005, Pages 626-641
Gail A. Bernstein,
Ann E. Layne, Elizabeth A. Egan and Lara P. Nelson
Journal
of Anxiety Disorders. Volume 19, Issue 6, 2005, Pages 658-672